Skip to content

Oocyte Zygote Embryo Maturation Arrest 16 C4310659

Published: July 22, 2026Updated: August 25, 2026

A genetic condition causing early embryo development to stop, leading to recurrent IVF failures or miscarriage in women of reproductive age.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(reproductive)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Infertility

(reproductive)

Embryonic developmental arrest

(reproductive)

Irregular menstrual cycles

(reproductive)

Recurrent miscarriage

(reproductive)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Advanced IVF with extended culture

Modified ovarian stimulation protocol with extended embryo culture to assess maturation potential at multiple developmental stages from oocyte through embryo.

procedure
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Personalized gonadotropin protocol

Tailored hormonal stimulation using FSH and LH combinations based on patient's ovarian reserve and previous response patterns to optimize oocyte quality.

medication

Additional treatment options

Donor oocyte or embryo adoption

Complete replacement of patient-derived gametes with donor oocytes or adoption of donated embryos when patient-derived material shows consistent maturation arrest.

procedure

Antioxidant and cofactor supplementation

Nutritional support including CoQ10, folate, omega-3 fatty acids, and B vitamins to support mitochondrial function and cellular maturation processes.

dietary

Traditional Chinese Medicine integration

Acupuncture and herbal medicine approaches used alongside conventional ART to potentially improve ovarian function and treatment response.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Oocyte Zygote Embryo Maturation Arrest 16 C4310659?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Oocyte Zygote Embryo Maturation Arrest 16 C4310659. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy